Skip to main content
VulnerabilityPublished

CVE-2026-24217: NVIDIA BioNeMo Framework · Path Traversal: '\..\filename

Affects NVIDIA BioNeMo FrameworkSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 8.8 High : upgrade to commit dfd83a7 on main soon.

Data as of 30 Oct 2026, 11:52 UTC

CVSS 3.1 base score
8.8High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.7% chance of exploitation in 30 days – higher than 55% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in commit dfd83a7 on main
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 May 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.

What to do

Upgrade NVIDIA BioNeMo Framework to commit dfd83a7 on main.

Affected software

ProductAffectedFixed in
NVIDIABioNeMo FrameworkAffected
  • =0
Fixed in
  • commit dfd83a7 on main

AI-suggested

If you cannot patch yet, users should exercise caution when loading files in the BioNeMo Framework and restrict access to trusted sources only.

Description

NVIDIA BioNeMo Core for Linux has a path traversal vulnerability (CWE-29) that allows a user to load a malicious file using a crafted path such as '\.. \filename'. Exploiting this vulnerability could lead to code execution, denial of service, information disclosure, and data tampering. The vulnerability has a high severity with a CVSS score of 8.8. There are no known exploits in the wild at this time.

References

Community reviews

Loading reviews…